Yang Yang
Clinical Cardiac Electrophysiology · Fayetteville, ARNPI 1477930295
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (44.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Biosense Webster, Inc. at 33.2% of the total.
Across 298 payments — averaging $98.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$10K
- Biotronik Inc.$6K
- Boston Scientific$6K
- Abbott$3K
- Medtronic$2K
- Atricure, Inc.$630
- plus $1K from 18 others
What the payments were for
- Consulting fees$2,2508%
- Grants$1,3875%
- Travel & lodging$13,10245%
- Food & beverage$12,06741%
- Education$4361%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 56 | $9,718 |
| Biotronik Inc. | 31 | $6,323 |
| Boston Scientific | 49 | $6,289 |
| Abbott | 81 | $2,896 |
| Medtronic | 22 | $2,292 |
| Atricure, Inc. | 8 | $630 |
| Pfizer | 20 | $360 |
| Baylis Medical Company Inc | 3 | $236 |
| Novartis | 5 | $73 |
| Novo Nordisk | 3 | $63 |
| AstraZeneca | 3 | $49 |
| Merck | 3 | $45 |
| Silk Road Medical, Inc. | 1 | $40 |
| Johnson & Johnson | 2 | $31 |
| Bridgebio Pharma, Inc. | 2 | $30 |
| Ultragenyx Pharmaceutical Inc. | 1 | $27 |
| Irhythm Technologies, Inc. | 1 | $22 |
| Stryker | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Chiesi USA, Inc. | 1 | $16 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $16 |
| Amgen | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$3,634
- Farapulse$3,064
- Sentus$1,840
- Acticor$1,383
- Edora$1,383
- Acticor 7 VR-T DX$1,209
- Edora 8 DR-T$1,059
- Rivacor 7 DR-T$1,059
- Rivacor$881
- Plexa$781
- ENSITE PRECISION$642
- BioMonitor$602
- Solia$602
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$458
- AURORA EV-ICD MRI SURESCAN$233
- VersaCross Access Solution$179
- RHYTHMVIEW$168
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$166
- QUARTET$147
- ENSITE$136
How this compares
$29,241 in reported general payments places this provider in the 60th percentile of 25 clinical cardiac electrophysiology providers in Arkansas.
See all clinical cardiac electrophysiology providers in Arkansas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 196 | $169,350 |
| XareltoRivaroxaban | 38 | $39,580 |
| Dofetilide | 45 | $8,870 |
| Amiodarone Hcl | 166 | $2,366 |
| Flecainide Acetate | 38 | $2,141 |
| Colchicine | 116 | $1,662 |
| Metoprolol Succinate | 110 | $1,328 |
| SotalolSotalol Hcl | 30 | $937 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 29 | $651 |
| Omeprazole | 103 | $510 |
| Digoxin | 15 | $367 |
| Potassium Chloride | 21 | $242 |
| Carvedilol | 34 | $226 |
| Warfarin Sodium | 21 | $199 |
| Metoprolol Tartrate | 45 | $141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $360 | $169,350196 claims |
| Johnson & JohnsonXarelto | $31 | $39,58038 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 25 clinical cardiac electrophysiology providers in Arkansas.
Other clinical cardiac electrophysiology in Fayetteville
- Boris BogomilovFayetteville$9K
- Soliman SolimanFayetteville$3K
- Devi NairJonesboro$1.8M
- Monica LoLittle Rock$190K
- Oreoluwa OladiranJonesboro$80K
- Sudarone ThihalolipavanLittle Rock$77K
- Prabhat HebbarLittle Rock$75K
- Raphael NgengweJonesboro$47K
- Bilal SaqiNorth Little Rock$44K
- Gerald GreerLittle Rock$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.